Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Novo Holding
Deal Size : $28.1 million
Deal Type : Financing
Orbis Medicines Launches with €26 Million Seed Financing for Macrocycle Drugs
Details : The funding will support Orbis’ expansion and advancement of its next-generation macrocycle drugs, known as nCycles, designed for oral bioavailability and membrane permeability.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 29, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Novo Holding
Deal Size : $28.1 million
Deal Type : Financing